Skip to main content
Premium Trial:

Request an Annual Quote

Cartagenia Opens US Office

NEW YORK (GenomeWeb News) – Cartagenia has opened its first North American office in Boston, the Leuven, Belgium-based bioinformatics firm said today.

The opening of the new office follows recently signed contracts with GeneDx and the Los Angeles Children's Hospital.

The firm also said that it has named Drew Arnold, VP of sales and business development for North America, to head the office. He joins Cartagenia from GenomeQuest, where he headed the global sales team.

Cartagenia makes software and database systems for clinically relevant genetic analysis.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.